Limits...
4-[2,3-Dibromo-3-(4-bromo-phen-yl)propano-yl]-2-phenyl-1,2,3-oxadiazol-2-ium-5-olate.

Fun HK, Shahani T - Acta Crystallogr Sect E Struct Rep Online (2010)

Bottom Line: In the major component, the 1,2,3-oxadiazo-lidine ring is essentially planar [maximum deviation = 0.017 (6) Å] and makes dihedral angles of 22.5 (3) and 70.2 (3)° with the 4-bromo-phenyl and phenyl rings, respectively.In the crystal, inter-molecular C-H⋯Br hydrogen bonds link the mol-ecules into ribbons along [010].In the major component, the mol-ecular structure is stabilized by an intra-molecular C-H⋯O hydrogen bond, which forms an S(6) ring motif.

View Article: PubMed Central - HTML - PubMed

ABSTRACT
In the title compound, C(17)H(11)Br(3)N(2)O(3), the whole mol-ecule is disordered over two positions with a refined occupancy ratio of 0.770 (5):0.230 (5). In the major component, the 1,2,3-oxadiazo-lidine ring is essentially planar [maximum deviation = 0.017 (6) Å] and makes dihedral angles of 22.5 (3) and 70.2 (3)° with the 4-bromo-phenyl and phenyl rings, respectively. In the minor component, the corresponding values are 18.9 (11) and 84.9 (12)°. In the crystal, inter-molecular C-H⋯Br hydrogen bonds link the mol-ecules into ribbons along [010]. There is a short O⋯N contact [2.83 (3) Å] in the minor component. In the major component, the mol-ecular structure is stabilized by an intra-molecular C-H⋯O hydrogen bond, which forms an S(6) ring motif.

No MeSH data available.


Related in: MedlinePlus

The crystal packing of the title compound, viewed along c axis. Only the major disordered component is shown. Hydrogen atoms not involved in intermolecular hydrogen bonding (dashed lines) are omitted for clarity.
© Copyright Policy - open-access
Related In: Results  -  Collection

License
getmorefigures.php?uid=PMC3009087&req=5

Fap2: The crystal packing of the title compound, viewed along c axis. Only the major disordered component is shown. Hydrogen atoms not involved in intermolecular hydrogen bonding (dashed lines) are omitted for clarity.


4-[2,3-Dibromo-3-(4-bromo-phen-yl)propano-yl]-2-phenyl-1,2,3-oxadiazol-2-ium-5-olate.

Fun HK, Shahani T - Acta Crystallogr Sect E Struct Rep Online (2010)

The crystal packing of the title compound, viewed along c axis. Only the major disordered component is shown. Hydrogen atoms not involved in intermolecular hydrogen bonding (dashed lines) are omitted for clarity.
© Copyright Policy - open-access
Related In: Results  -  Collection

License
Show All Figures
getmorefigures.php?uid=PMC3009087&req=5

Fap2: The crystal packing of the title compound, viewed along c axis. Only the major disordered component is shown. Hydrogen atoms not involved in intermolecular hydrogen bonding (dashed lines) are omitted for clarity.
Bottom Line: In the major component, the 1,2,3-oxadiazo-lidine ring is essentially planar [maximum deviation = 0.017 (6) Å] and makes dihedral angles of 22.5 (3) and 70.2 (3)° with the 4-bromo-phenyl and phenyl rings, respectively.In the crystal, inter-molecular C-H⋯Br hydrogen bonds link the mol-ecules into ribbons along [010].In the major component, the mol-ecular structure is stabilized by an intra-molecular C-H⋯O hydrogen bond, which forms an S(6) ring motif.

View Article: PubMed Central - HTML - PubMed

ABSTRACT
In the title compound, C(17)H(11)Br(3)N(2)O(3), the whole mol-ecule is disordered over two positions with a refined occupancy ratio of 0.770 (5):0.230 (5). In the major component, the 1,2,3-oxadiazo-lidine ring is essentially planar [maximum deviation = 0.017 (6) Å] and makes dihedral angles of 22.5 (3) and 70.2 (3)° with the 4-bromo-phenyl and phenyl rings, respectively. In the minor component, the corresponding values are 18.9 (11) and 84.9 (12)°. In the crystal, inter-molecular C-H⋯Br hydrogen bonds link the mol-ecules into ribbons along [010]. There is a short O⋯N contact [2.83 (3) Å] in the minor component. In the major component, the mol-ecular structure is stabilized by an intra-molecular C-H⋯O hydrogen bond, which forms an S(6) ring motif.

No MeSH data available.


Related in: MedlinePlus